Clinical Trial

Pressure Pain Tolerance in Relation to Balance and Strength in Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Sickle cell disease (SCD) is the most frequent life-threatening genetic hemoglobinopathy in the world and occurs due to the synthesis of abnormal hemoglobin S (HbS).Cells with sickle cell hemoglobin are stiff and sticky. When they lose their oxygen, they form into the shape of a sickle or crescent. This can cause pain and tissue damage. Significant decrease in exercise capacity was seen in sickle cell anemic children. In the absence of a guidelines that can guide the prescription of exercise in SCD children. This study is a step for determine the forms of prescription of pain on the balance and muscle strength to build up in future studies a safety of physical exercises for children with sickle cell anemia and improve their functional abilities.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-29.
Trial Details
NCT Number NCT06529874
Lead Sponsor Adly A Adam
Conditions Sickle Cell Anemia
Enrollment 80 participants
Start Date 2024-02-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-01